Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tag: Avastin


The limitations of progression-free survival as an endpoint – NPR addresses


Emotion, anecdotes, politics and ugliness in Avastin aftermath


Clash between data and emotion in FDA decision on Avastin for metastatic breast cancer